Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-24

FDA Approved: ROSUVASTATIN — Original Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original ANDA for a generic rosuvastatin product, manufactured by ScieGen Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)

Snippet

ORIG AP for ROSUVASTATIN (ROSUVASTATIN)